Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Asia-wide Genome Mapping Project Reveals Insights Into Asian Ancestry, Genetic Diversity

    Dec 6, 2019, 08:30 AM by Michael Croft

    Bio-IT World News Brief | In their first study reported in Nature this week, the GenomeAsia 100K consortium analyzed the genomes of 1,739 people, which represents the widest coverage of genetic diversity in Asia to date.

    Full story
  • Scilligence and Certara Partner to Improve Client’s Data Analysis and Visualization

    Dec 5, 2019, 15:07 PM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Dec 5, 2019 - Scilligence, an innovation leader of unified informatics platform for biologics and small molecules drug R&D, has partnered with Certara to enable advanced data analysis and visualization capabilities
    Full story
  • CluePoints’ Risk-Based Quality Management Software Wins Best Technological Development in Clinical Trials at SCRIP Awards 2019

    Dec 5, 2019, 10:46 AM by Michael Croft
    KING OF PRUSSIA, PA - Dec 5, 2019 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, today announced that it has been awarded best technological development in clinical trials in the 2019 Scrip Awards
    Full story
  • To Advance Polygenic Risk Scores, Large Studies Need Better Genotyping Tools

    Dec 5, 2019, 07:45 AM by Michael Croft

    Bio-IT World Contributed Commentary | A decade ago, the concept of a polygenic risk score had not even been cited in a genomics publication. Today, it’s almost impossible to pick up a human genetics journal or attend a conference without hearing about these new biomarkers.

    Full story
  • VeraSci's Innovation Lab Launches Wearable Technology Validation Study

    Dec 4, 2019, 14:50 PM by Michael Croft
    DURHAM, NC, UNITED STATES - Dec 4, 2019 - VeraSci's Innovation Lab led by Dr. Alexandra Atkins has begun evaluating the ease of use, sensitivity, and reliability of two industry-grade wearable devices for the real-time capture of gait and actigraphy measuresx
    Full story
  • The Nose Knows: Developing Artificial Intelligence Sniffers

    Dec 4, 2019, 10:30 AM by Michael Croft

    Bio-IT World | When you think of artificial intelligence, what comes to mind? A computer brain? Computer vision? Auditory language processing? What about smell? It’s an area of research IBM is busy exploring.

    Full story
  • FDA Awards DNAnexus with Five-Year, $20 Million Contract to Power precisionFDA Collaborative Omics Environment in the Cloud

    Dec 3, 2019, 13:14 PM by Michael Croft
    MOUNTAIN VIEW, CA, UNITED STATES - Dec 3, 2019 - DNAnexus, Inc., the leader in Enterprise Omics Technology, today announced that the U
    Full story
  • Absolute Antibody Partners with the Recombinant Antibody Network to Facilitate Access to Engineered Recombinant Antibodies

    Dec 3, 2019, 10:17 AM by Michael Croft
    REDCAR, UNITED KINGDOM - Dec 3, 2019 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert centers at the University of Chicago, University of Toronto, and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies at a proteome-wide scale
    Full story
  • Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research

    Dec 3, 2019, 07:47 AM by Michael Croft
    CAMBRIDGE AND LONDON, UNITED KINGDOM - Dec 3, 2019 - Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical research charity, today announced an extension of their neuroscience-focused ion channel drug discovery collaboration, following the success of the initial twelve-month agreement
    Full story
  • Hypha Discovery announces “One-Stop Metabolite Shop” solution to support pharmaceutical and agrochemical R&D

    Dec 3, 2019, 05:22 AM by Michael Croft
    SLOUGH, UK - Dec 3, 2019 - Hypha Discovery Limited, a leading specialist CRO, has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwide
    Full story
  • Benchling: Enabling the Next Generation of Data and Workflow Tracking

    Dec 2, 2019, 10:35 AM by Michael Croft
    Bio-IT World Benchling’s value proposition is easy to see. For researchers—whether in an academic lab, small biotech, or big pharma—keeping track of research using paper lab notebooks, email, and spreadsheets is cumbersome and inefficient. But the challenges to science are much bigger than just misplaced notes or forgotten results. The real value, says Saji Wickramasekara, comes from enabling a new level of collaboration and data provenance.
    Full story
  • TrialScope Launches Clinical Trials Website for EMD Serono

    Dec 2, 2019, 09:31 AM by Michael Croft
    JERSEY CITY, NJ, UNITED STATES - Dec 2, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has worked with EMD Serono, the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, to launch a new website, https://clinicaltrials
    Full story
  • One Nucleus announces finalists of the BioNewsRound Award

    Nov 28, 2019, 06:24 AM by Michael Croft
    LONDON, UK - Nov 28, 2019 - One Nucleus reveals the finalists of its annual BioNewsRound Award, recognising life science companies that have announced exciting developments for patients and the sector
    Full story
  • Creative Peptides Provides Photo Cross Linkers for Custom Labeling in Peptide Modification

    Nov 27, 2019, 22:22 PM by Michael Croft
    NY, NY, UNITED STATES - Nov 28, 2019 - The global leading peptide supplier Creative Peptides announces to release a product line of photo cross linkers for researchers who are engaged with custom labeling, peptide bioconjugation as well as peptide modification
    Full story
  • Enzymes for Cancer Treatment Manufactured by Creative Enzymes Have Set New Pace for Medical Science

    Nov 27, 2019, 22:08 PM by Michael Croft
    NEW YORK, NY - Nov 28, 2019 - Creative Enzymes, a cutting-edge enzyme product and service provider based in NY, USA, has recently published enzymes for cancer treatment to help scientists in the area of medicine
    Full story
  • BOC Sciences Rearranges Chemical Analysis and Purification Service for Drug Discovery Projects

    Nov 27, 2019, 21:06 PM by Michael Croft
    SHIRLEY, NY, NY, UNITED STATES - Nov 28, 2019 - In response to the ever-increasing demand in new drug discovery and development, medicinal chemistry has progressed at a fast pace during the last ten years
    Full story
  • Signant Health Joins the Association of Clinical Research Organizations (ACRO) to Add a Technology Perspective to Industry Conversations

    Nov 27, 2019, 11:09 AM by Michael Croft
    PHILADELPHIA, PA - Nov 27, 2019 - Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO)
    Full story
  • HudsonAlpha, Vanderbilt, Thermo Scientific, and More: News From November 2019

    Nov 27, 2019, 08:40 AM by Michael Croft

    Bio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including HudsonAlpha, Vanderbilt, Thermo Scientific, and more.

    Full story
  • Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever

    Nov 26, 2019, 04:50 AM by Michael Croft
    LONDON, UK - Nov 26, 2019 - Prokarium, a private biotechnology company developing vaccines against infectious diseases and immunotherapy for solid tumors, has received Clinical Trial Authorization (CTA) acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a first-in-human Phase I trial with Entervax™, a bivalent vaccine against enteric fever
    Full story
  • SAKOR Technologies Announces Dynamometer Line for Testing Electric Motor Efficiency to Meet International Environmental Standards

    Nov 25, 2019, 14:27 PM by Michael Croft
    OWOSSO, MI, UNITED STATES - Nov 25, 2019 - For Immediate ReleaseContact:          Judi Handel                        McNeil, Gray & Rice                        617-367-0100 ext
    Full story
  • «
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219 (current)
  • 220
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy